The Centre for Research on Brain, Language and Music (CRBLM) at McGill University is a Regroupement Stratégique whose mission is to promote research and training in the areas of language and music neuroscience, performance, and development. Participating universities include McGill, Université de Montréal, UQAM, and Concordia. Our infrastructure for language and music research is unparalleled, including research facilities located in the McGill Faculties of Medicine, Science, Arts, and Education, as well as the International Laboratory for Brain and Music Research (BRAMS) located at the Université de Montréal. Our specific objectives include:
The MCSA is committed to investigating causes and possible treatments of the dementias, especially Alzheimer's disease. During the past decades, the MCSA has played a pioneering role in identifying genetic abnormalities leading to an increased risk for Alzheimer's disease. The Memory Clinic of the Alzheimer's Disease Research Unit, under the leadership of Dr. Serge Gauthier, is focusing on improved therapies, long-term treatment of subjects affected by dementia, and enhancing the quality of life of patients and caregivers. Prevention, the new major focus of aging research, has been identified as an important objective in dementia research by national and international institutes (Alzheimer Society of Canada, National Institute of Aging USA) and is a priority of McGill University over the next decade. The McGill Centre for Studies in Aging contributes to this effort with its Dementia Prevention Program (www.ponder.mcgill.ca). This program, in close cooperation with the Douglas Institute and other research centres in Quebec, will allow community prevention and initiate optimal treatment for affected individuals while providing researchers with important data about possible predictors of dementia. Further, the MCSA has established a computational infrastructure devoted for teaching neuroimaging in dementia for fellows, graduate, and postdoctoral students. This infrastructure program is under the direction of Dr. Pedro Rosa-Neto, M.D., Ph.D. Finally, research in the field of neuroimaging has been focusing on the early detection of dementia, and AD prevention.